{"id":530673,"date":"2021-02-17T16:48:01","date_gmt":"2021-02-17T16:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=530673"},"modified":"2021-02-17T16:48:01","modified_gmt":"2021-02-17T16:48:01","slug":"active-pharmaceutical-ingredients-market-202126-size-share-price-and-industry-trends","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/active-pharmaceutical-ingredients-market-202126-size-share-price-and-industry-trends_530673.html","title":{"rendered":"Active Pharmaceutical Ingredients Market 2021-26: Size. Share, Price and Industry Trends"},"content":{"rendered":"
\"Active<\/a><\/p>\n
\n
Active Pharmaceutical Ingredients Market<\/div>\n<\/div>\n<\/div>\n
According to IMARC Group expects the global active pharmaceutical ingredients (API) market to projected to reach moderate growth during 2021-2026.<\/div>\n

IMARC Group’s latest report, titled “Active Pharmaceutical Ingredients Market<\/strong>: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025<\/strong>”, finds that the global active pharmaceutical ingredients market size reached a value of US$ 200.6 Billion<\/strong><\/a> in 2020. Active pharmaceutical ingredient (API) refers to the biological substance or combination of substances used in a pharmaceutical drug (e.g., tablet, capsule). It is one of the primary ingredients utilized in the manufacturing of medicines. In combination therapies, two or more active ingredients are used to trea0t different disease symptoms. Stringent quality control regulations are followed in the manufacturing of APIs as they represent the main component considered while making the prescription.<\/p>\n

Request Free Sample Report:<\/strong> https:\/\/www.imarcgroup.com\/active-pharmaceutical-ingredients-market\/requestsample<\/p>\n

The increasing affordability of active pharmaceutical ingredients is primarily driving the market growth. Additionally, the growing number of blockbuster patent expiries are creating enormous opportunities for generic APIs. The market is further catalyzed by the high potency of APIs to treat diseases beyond the scope of small molecule drugs. Other factors, including the growing geriatric population, rising expenditures on healthcare services, increasing prevalence of lifestyle diseases, etc., will continue to drive the market for APIs. Looking forward, IMARC Group expects the global active pharmaceutical ingredients (API) market to exhibit moderate growth during the forecast period (2021-2026).<\/p>\n

Market Breakup by Drug Type<\/strong>:<\/p>\n